Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
ORAMED PHARMACEUTICALS INC. has filed 932 SEC EDGAR filings since 29 Nov 2002

SEC filing history

Showing 101-125 of 773 matching filings.

Per page
25
Current page
5
8-K File 001-35813

CURRENT REPORT

Filing date
23 Sep 2024
Reporting date
20 Sep 2024
Next action
Verify source filing
SC 13G File 005-79895

SC 13G filing

Filing date
16 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
02 Aug 2024
Reporting date
01 Aug 2024
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
26 Jun 2024
Reporting date
26 Jun 2024
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
24 Jun 2024
Reporting date
20 Jun 2024
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2024
Reporting date
21 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
21 Jun 2024
Reporting date
18 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-35813

FORM ARS

Filing date
20 Jun 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35813

DEFINITIVE PROXY STATEMENT

Filing date
20 Jun 2024
Reporting date
01 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
10 Jun 2024
Reporting date
06 Jun 2024
Next action
Verify source filing
4

4 filing

Filing date
10 Jun 2024
Reporting date
06 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
13 May 2024
Reporting date
10 May 2024
Next action
Verify source filing
10-Q File 001-35813

QUARTERLY REPORT

Filing date
09 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
06 May 2024
Reporting date
02 May 2024
Next action
Verify source filing
4

4 filing

Filing date
18 Apr 2024
Reporting date
17 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
02 Apr 2024
Reporting date
01 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-79895

SCHEDULE 13D

Filing date
22 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
19 Mar 2024
Reporting date
14 Mar 2024
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
18 Mar 2024
Reporting date
12 Mar 2024
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
18 Mar 2024
Reporting date
18 Mar 2024
Next action
Verify source filing
424B5 File 333-257926

PROSPECTUS SUPPLEMENT

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-35813

ANNUAL REPORT

Filing date
06 Mar 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
8-K File 001-35813

CURRENT REPORT

Filing date
20 Feb 2024
Reporting date
20 Feb 2024
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jan 2024
Reporting date
30 Jan 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .